| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 12/27/2001 | WO2001097858A2 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
| 12/27/2001 | WO2001097855A2 Targeted combination immunotherapy of cancer and infectious diseases |
| 12/27/2001 | WO2001097848A2 Vitronectin receptor antagonist pharmaceuticals |
| 12/27/2001 | WO2001097678A2 Imaging and targeting tumors using sickle cells |
| 12/27/2001 | WO2001047564A3 Labelled ascorbic acid derivatives |
| 12/27/2001 | WO2001040239A3 Transition metal-cyclopentadienyl-tropane conjugates |
| 12/27/2001 | US20010055595 Detection and treatment of infections with immunoconjugates |
| 12/27/2001 | US20010055565 Method of detecting cyclooxygenase-2 |
| 12/27/2001 | US20010055563 Post-labeling stabilization of radiolabeled proteins and peptides |
| 12/27/2001 | CA2713965A1 Glycopeptide phosphonate derivatives |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2412849A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 12/27/2001 | CA2411826A1 Liposomal encapsulation of chelated actinium-225 and uses thereof |
| 12/27/2001 | CA2411102A1 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
| 12/25/2001 | US6333402 For therapy and diagnosis |
| 12/25/2001 | US6333051 Nanogel networks and biological agent compositions thereof |
| 12/25/2001 | US6333020 Methods for treating AVM's using radio active compositions |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001062207A3 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 12/20/2001 | WO2001017566A3 L-selectin contrast agents |
| 12/20/2001 | WO2001013949A3 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 12/20/2001 | WO1998024481A3 A radiolabelled ligand for selective introduction into the nucleus of a cancer cell |
| 12/20/2001 | US20010053538 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 12/20/2001 | US20010053371 Molecule having an IL13-moiety and a cytotoxic moiety; especially for reducing growth of glioblastoma multiforme cells. |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
| 12/19/2001 | EP1163524A2 Methods of screening for colorectal cancer modulators |
| 12/19/2001 | EP1163272A1 Antibodies specific for cyp1b1 |
| 12/19/2001 | EP1163231A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics |
| 12/19/2001 | EP1163013A2 Colloid for scintigraphy |
| 12/19/2001 | EP0750649B1 Branched polyoxaalkyl macromolecules, process for making them and their uses |
| 12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
| 12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
| 12/18/2001 | US6331394 Contacting candidate mixture of nucleic acids with integrin, wherein nucleic acids having increased affinity to integrin relative to candidate mixture may be partitioned from remainder of mixture, partitioning, amplififying |
| 12/18/2001 | US6331289 Targeted diagnostic/therapeutic agents having more than one different vectors |
| 12/18/2001 | US6331287 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside |
| 12/18/2001 | US6331285 Structurally determined cyclic metallo-constructs and applications |
| 12/18/2001 | US6331175 Method and kit for imaging and treating organs and tissues |
| 12/13/2001 | WO2001094641A2 Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas |
| 12/13/2001 | WO2001093918A2 Radioimaging probes and the use thereof |
| 12/13/2001 | WO2001093913A2 T cell receptor fusions and conjugates and methods of use thereof |
| 12/13/2001 | WO2000029501A9 Radioactive coating solutions, methods, and substrates |
| 12/13/2001 | DE10026485A1 System mit einem Trägersubstrat mit einer Ti/P- bzw. AI/P-Beschichtung System comprising a support substrate with a Ti / P or Al / P coating |
| 12/13/2001 | CA2411586A1 Radioimaging probes and the use thereof |
| 12/13/2001 | CA2411470A1 T cell receptor fusions and conjugates and methods of use thereof |
| 12/12/2001 | EP1162626A1 Radioactive microsphere and method for preparation thereof |
| 12/12/2001 | EP1161266A1 Matriptase, a serine protease and its applications |
| 12/12/2001 | EP0750610B1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis |
| 12/12/2001 | EP0662075B1 Prostaglandin analog for treating osteoporosis |
| 12/12/2001 | EP0646019B1 Biotin-DOTA conjugates and their use in pretargeting methods |
| 12/12/2001 | CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
| 12/12/2001 | CN1325732A Nm-class magnetic material carrying radioisotope and its preparing process |
| 12/12/2001 | CN1075959C Radioactive particulate material, preparation and use thereof |
| 12/11/2001 | US6329520 Used as imaging or pharmaceutical agents, in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases or in determining doses of therapeutic agents that occupy many receptors |
| 12/11/2001 | US6329513 Cores for technetium radiopharmaceuticals |
| 12/11/2001 | US6329508 Has variable region which binds to transferrin receptors on brain capillary endothelial cells; for drug or diagnostic agent delivery across blood-brain barrier |
| 12/11/2001 | US6329507 Dimer and multimer forms of single chain polypeptides |
| 12/11/2001 | US6328700 Locating marker/tracer elements detectable by neutron activated analysis within or on carrier microspheres, including microspheres used in biological experimentation |
| 12/06/2001 | WO2001092528A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | WO2001092288A2 Cobalamin compounds useful as antibiotic agents and as imaging agents |
| 12/06/2001 | WO2001091823A1 System comprising a carrier substrate and a ti/p or. ai/p coating |
| 12/06/2001 | WO2001091808A2 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 12/06/2001 | WO2001091807A2 Ethylenedicysteine (ec)-drug conjugates |
| 12/06/2001 | WO2001091806A2 Measurement of the therapeutic dose for bone marrow ablation therapy |
| 12/06/2001 | WO2001091805A2 Compounds for targeting endothelial cells |
| 12/06/2001 | WO2001091804A1 Detectably labeled porphyrin compound for identifying the sentinel lymph node |
| 12/06/2001 | WO2001054734A3 188re-labelled 5-thio-d-glucose for radionucleotide tumor therapy |
| 12/06/2001 | WO2000062808A8 Cobalamin conjugates useful as antitumor agents |
| 12/06/2001 | US20010048914 Radioactive therapeutic liposomes |
| 12/06/2001 | CA2411651A1 Detectably labeled porphyrin compound for identifying the sentinel lymph node |
| 12/06/2001 | CA2410436A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/05/2001 | EP1038300B1 Highly radioactive miniaturized ceramic strontium 90 radiation source and method for the production thereof |
| 12/05/2001 | EP0835263B1 Somatostatin peptides |
| 12/05/2001 | CN1325534A Apparatus and method for brachytherapy |
| 12/05/2001 | CN1325405A Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 12/05/2001 | CN1325315A Implant with cavities containing therapeutic agents |
| 11/29/2001 | WO2001090114A1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation |
| 11/29/2001 | WO2001089586A2 Tc and re carbonyl complexes for pertechnetate and perrhenate |
| 11/29/2001 | WO2001089584A2 Contrast agents |
| 11/29/2001 | WO2001089501A1 Polymerizable compositions and methods of use |
| 11/29/2001 | WO2001089380A2 Combined impedance imaging and mammography |
| 11/29/2001 | WO2001089379A1 Apparatus for impedance imaging coupled with another modality |
| 11/29/2001 | WO2001005433A3 Delivery and retention of activity agents to lymph nodes |
| 11/29/2001 | WO2001003745A3 Therapy and diagnosis of colorectal cancer with radiopharmaceuticals |
| 11/29/2001 | US20010047185 Radioactivatable composition and implantable medical devices formed therefrom |
| 11/29/2001 | US20010047028 8-azabicyclo(3.2.1)oct-2-ene and 9-azabicyclo(3.3.1)non-2-ene derivatives; monoamine neurotransmitter and serotonine reuptake inhibitors; radionuclide-labeled derivatives for diagnosis and detection |
| 11/29/2001 | US20010046983 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 11/29/2001 | US20010046470 Diagnoses and treatment of disorders using an alternative glucose pathway |
| 11/29/2001 | DE10026540A1 Gegenstand, insbesondere Implantat Object, in particular implant |
| 11/29/2001 | CA2309795A1 Radiopharmaceutical products for selective marking of lymphocytes and preparation of said products |
| 11/28/2001 | EP1157702A1 Compositions comprising DNA Damaging Agents and p53 |
| 11/28/2001 | EP1157076A1 Radioactive coating solutions, methods, and substrates |
| 11/28/2001 | EP1157004A1 Regioselective synthesis of dtpa derivatives |
| 11/28/2001 | EP1156835A2 Kit for radiolabeling proteins with yttrium-90 |
| 11/28/2001 | CN1075389C Sol prepn. of rhenium nucleic labeled iodanated oil and its preparing process and application |
| 11/27/2001 | US6323313 Genetically engineered binding protein for use in diagnosis, detection and treatment of vascular system thrombosis |
| 11/27/2001 | US6322771 Parenterally administering to a mammal a purine derivative to diagnose coronary artery stenosis |
| 11/27/2001 | US6322770 Indazole vitronectin receptor antagonist pharmaceuticals |
| 11/27/2001 | CA2137009C Technetium-99m labeled peptides for imaging |
| 11/22/2001 | WO2001088108A1 Neuronal serine-threonine protein kinase |
| 11/22/2001 | WO2001087354A2 Use of small molecule radioligands for diagnostic imaging |